Insider · CIK 0001727357
Tactic Pharma LLC
Files at MNPR (Monopar Therapeutics). First filing -, latest -.
Tactic Pharma LLC files SEC Form 4 as 10% owner at MNPR (Monopar Therapeutics). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tactic Pharma LLC has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 2, 2025 | MNPR Monopar Therapeutics | 33,334 0.55% of outstanding | $1.2M | Apr 2, 2025 | none |
Transactions
Every row this insider has filed, 0 in all, newest first.
Questions about Tactic Pharma LLC
Answered from the filings on this page, as of the latest one.
Is Tactic Pharma LLC buying or selling?
Tactic Pharma LLC has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tactic Pharma LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tactic Pharma LLC has 0.
Where does Tactic Pharma LLC file Form 4?
Tactic Pharma LLC has filed Form 4 at MNPR (Monopar Therapeutics). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.